Peter Switzer speaks to Kazia Therepeutics (KZA) CEO James Garner about the company's work to develop a new drug for cancer.
Peter Switzer speaks to Kazia Therepeutics (KZA) CEO James Garner about the company's work to develop a new drug for cancer.
I’m getting ready for negative headlines and an overreacting media this week, which will fan the fires of global stock markets. But here’s another strategy.
What is gout? Does it only afflict middle-aged men who libate too much?
The first Australian death from coronavirus has been announced, the Louvre is closed and fears increase as impact of coronavirus on the economy is predicted.
In this week's The Check Up, Dr Ross Walker explains why Vitamins may not be good for you.
At long last the Americans on Wall St are taking the Coronavirus seriously so let me give you a history lesson on stock market corrections.
Will we see a rapid normalization in economic growth rates and corporate fundamentals when this virus is ultimately contained?
A strange quirk of the statistical calendar is that each change of seasons in Australia is ushered in by a bevy of economic events. And so the ‘Autumn avalanche’ with more than a dozen indicators or events scheduled this week.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox